128 related articles for article (PubMed ID: 9288579)
21. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
[TBL] [Abstract][Full Text] [Related]
22. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
23. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
24. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to glutamic acid decarboxylase in the prediction of insulin dependency.
Zimmet P
Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S125-31. PubMed ID: 9015681
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
27. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
[TBL] [Abstract][Full Text] [Related]
28. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
29. Highly-sensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen.
Papouchado ML; Valdez SN; Ermácora MR; Gañan S; Poskus E
J Immunol Methods; 1997 Sep; 207(2):169-78. PubMed ID: 9368643
[TBL] [Abstract][Full Text] [Related]
30. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
Lühder F; Woltanski KP; Hamann J; Klöting I; Ziegler B; Ziegler M
Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
[TBL] [Abstract][Full Text] [Related]
31. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
[TBL] [Abstract][Full Text] [Related]
32. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
Wyatt RC; Brigatti C; Liberati D; Grace SL; Gillard BT; Long AE; Marzinotto I; Shoemark DK; Chandler KA; Achenbach P; Gillespie KM; Piemonti L; Lampasona V; Williams AJK
Diabet Med; 2018 Jul; 35(7):954-963. PubMed ID: 29577424
[TBL] [Abstract][Full Text] [Related]
33. Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.
Kawasaki E; Yano M; Abiru N; Akazawa S; Nagataki S
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):61-9. PubMed ID: 8803483
[TBL] [Abstract][Full Text] [Related]
34. Expression of recombinant human glutamic acid decarboxylase (GAD) in myeloma cells and enzyme-linked immunosorbent assay (ELISA) for autoantibodies to GAD.
Matsuba T; Yano M; Abiru N; Takino H; Akazawa S; Nagataki S; Yasukawa K
J Biochem; 1997 Jan; 121(1):20-4. PubMed ID: 9058186
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay.
Murata T; Tsuzaki K; Nirengi S; Watanabe T; Mizutani Y; Okada H; Tsukamoto M; Odori S; Nakagawachi R; Kawaguchi Y; Yoshioka F; Yamada K; Shimatsu A; Kotani K; Satoh-Asahara N; Sakane N
J Diabetes Investig; 2017 Jul; 8(4):475-479. PubMed ID: 27863109
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to GAD in Japanese diabetic patients: a multicenter study.
Tsuruoka A; Matsuba I; Toyota T; Isshiki G; Nagataki S; Ikeda Y
Diabetes Res Clin Pract; 1995 Jun; 28(3):191-9. PubMed ID: 8529498
[TBL] [Abstract][Full Text] [Related]
37. [Anti GAD (glutamic acid decarboxylase) antibody].
Yamanouchi T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():555-7. PubMed ID: 16149576
[No Abstract] [Full Text] [Related]
38. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies.
Vianello M; Keir G; Giometto B; Betterle C; Tavolato B; Thompson EJ
Eur J Neurol; 2005 Apr; 12(4):294-9. PubMed ID: 15804247
[TBL] [Abstract][Full Text] [Related]
39. Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice.
Oikawa Y; Kondo T; Shimada A; Seino Y; Kitaoka M
J Diabetes Investig; 2019 May; 10(3):685-689. PubMed ID: 30307126
[TBL] [Abstract][Full Text] [Related]
40. Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase.
Davenport C; Lovell H; James RF; Todd I
Clin Exp Immunol; 1995 Jul; 101(1):127-35. PubMed ID: 7621582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
